Glenmede Trust’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Glenmede Trust’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-198	Closed	-$2K	–	2767
2016 Q2	$2K	Hold	198	–	–	﹤0.01%	2428
2016 Q1	$2K	Hold	198	–	–	﹤0.01%	2448
2015 Q4	$3K	Hold	198	–	–	﹤0.01%	2423
2015 Q3	$3K	Sell	198 -109,136	-100%	-$2.36M	﹤0.01%	2461
2015 Q2	$2.66M	Buy	109,334 +7,416	+7%	+$178K	0.02%	515
2015 Q1	$2.37M	Buy	101,918 +30,574	+43%	+$809K	0.02%	559
2014 Q4	$1.79M	Buy	71,344 +35,664	+100%	+$1.05M	0.01%	603
2014 Q3	$1.11M	Hold	35,680	–	–	0.01%	663
2014 Q2	$922K	Hold	35,680	–	–	0.01%	718
2014 Q1	$833K	Hold	35,680	–	–	0.01%	744
2013 Q4	$905K	Buy	+35,680	New	+$806K	0.01%	701

Glenmede Trust's SGNT Position: Q3 2016 in Review

Glenmede Trust sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 198 shares — an estimated $2K sold.

Glenmede Trust first reported a position in SGNT in Q4 2013 and held it in 11 quarters. The position peaked at $2.66M in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Glenmede Trust reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Glenmede Trust sold 198 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2K.
Glenmede Trust first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 11 quarters.
Glenmede Trust's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.66M in Q2 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.